Delivery of mRNA for the augmentation of proteins and enzymes in human genetic diseases

Details for Australian Patent Application No. 2010326132 (hide)

Owner Shire Human Genetic Therapies

Inventors Guild, Braydon Charles; Derosa, Frank; Heartlein, Michael; Concino, Michael

Agent Cullens

Pub. Number AU-A-2010326132

PCT Pub. Number WO2011/068810

Priority 61/265,653 01.12.09 US

Filing date 30 November 2010

Wipo publication date 9 June 2011

International Classifications

A61K 31/7105 - Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links

C07H 21/02 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

5 July 2012 PCT application entered the National Phase

  PCT publication WO2011/068810 Priority application(s): WO2011/068810

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010326133-Oral compositions containing extracts of Zingiber officinale and related methods

2010326130-Enzymatic activity based-detection